ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alpha1-Proteinase Inhibitor Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-34G7846
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Alpha1 Proteinase Inhibitor Market Insights and Forecast to 2028
BUY CHAPTERS

Global Alpha1-Proteinase Inhibitor Market Research Report 2025

Code: QYRE-Auto-34G7846
Report
September 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Kamada
Grifols S A
CSL Behring
Baxter
Talecris Biotherapeutics
Aventis

Alpha1-Proteinase Inhibitor Market Size

The global market for Alpha1-Proteinase Inhibitor was valued at US$ 8683 million in the year 2024 and is projected to reach a revised size of US$ 10230 million by 2031, growing at a CAGR of 2.4% during the forecast period.

Alpha1-Proteinase Inhibitor Market

Alpha1-Proteinase Inhibitor Market

North American market for Alpha1-Proteinase Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Alpha1-Proteinase Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Alpha1-Proteinase Inhibitor include Baxter, Kamada, Talecris Biotherapeutics, Aventis, CSL Behring, Grifols, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alpha1-Proteinase Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha1-Proteinase Inhibitor.
The Alpha1-Proteinase Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha1-Proteinase Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha1-Proteinase Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alpha1-Proteinase Inhibitor Market Report

Report Metric Details
Report Name Alpha1-Proteinase Inhibitor Market
Accounted market size in year US$ 8683 million
Forecasted market size in 2031 US$ 10230 million
CAGR 2.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Powder
  • Liquid
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, Kamada, Talecris Biotherapeutics, Aventis, CSL Behring, Grifols
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alpha1-Proteinase Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alpha1-Proteinase Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Alpha1-Proteinase Inhibitor Market growing?

Ans: The Alpha1-Proteinase Inhibitor Market witnessing a CAGR of 2.4% during the forecast period 2025-2031.

What is the Alpha1-Proteinase Inhibitor Market size in 2031?

Ans: The Alpha1-Proteinase Inhibitor Market size in 2031 will be US$ 10230 million.

Who are the main players in the Alpha1-Proteinase Inhibitor Market report?

Ans: The main players in the Alpha1-Proteinase Inhibitor Market are Baxter, Kamada, Talecris Biotherapeutics, Aventis, CSL Behring, Grifols

What are the Application segmentation covered in the Alpha1-Proteinase Inhibitor Market report?

Ans: The Applications covered in the Alpha1-Proteinase Inhibitor Market report are Hospital, Clinic

What are the Type segmentation covered in the Alpha1-Proteinase Inhibitor Market report?

Ans: The Types covered in the Alpha1-Proteinase Inhibitor Market report are Powder, Liquid

Recommended Reports

Protein Inhibitors

Protein/Enzyme Research

API & Therapeutics

1 Alpha1-Proteinase Inhibitor Market Overview
1.1 Product Definition
1.2 Alpha1-Proteinase Inhibitor by Type
1.2.1 Global Alpha1-Proteinase Inhibitor Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.3 Alpha1-Proteinase Inhibitor by Application
1.3.1 Global Alpha1-Proteinase Inhibitor Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Alpha1-Proteinase Inhibitor Market Size Estimates and Forecasts
1.4.1 Global Alpha1-Proteinase Inhibitor Revenue 2020-2031
1.4.2 Global Alpha1-Proteinase Inhibitor Sales 2020-2031
1.4.3 Global Alpha1-Proteinase Inhibitor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Alpha1-Proteinase Inhibitor Market Competition by Manufacturers
2.1 Global Alpha1-Proteinase Inhibitor Sales Market Share by Manufacturers (2020-2025)
2.2 Global Alpha1-Proteinase Inhibitor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Alpha1-Proteinase Inhibitor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Alpha1-Proteinase Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alpha1-Proteinase Inhibitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alpha1-Proteinase Inhibitor, Product Type & Application
2.7 Global Key Manufacturers of Alpha1-Proteinase Inhibitor, Date of Enter into This Industry
2.8 Global Alpha1-Proteinase Inhibitor Market Competitive Situation and Trends
2.8.1 Global Alpha1-Proteinase Inhibitor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Alpha1-Proteinase Inhibitor Players Market Share by Revenue
2.8.3 Global Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alpha1-Proteinase Inhibitor Market Scenario by Region
3.1 Global Alpha1-Proteinase Inhibitor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Alpha1-Proteinase Inhibitor Sales by Region: 2020-2031
3.2.1 Global Alpha1-Proteinase Inhibitor Sales by Region: 2020-2025
3.2.2 Global Alpha1-Proteinase Inhibitor Sales by Region: 2026-2031
3.3 Global Alpha1-Proteinase Inhibitor Revenue by Region: 2020-2031
3.3.1 Global Alpha1-Proteinase Inhibitor Revenue by Region: 2020-2025
3.3.2 Global Alpha1-Proteinase Inhibitor Revenue by Region: 2026-2031
3.4 North America Alpha1-Proteinase Inhibitor Market Facts & Figures by Country
3.4.1 North America Alpha1-Proteinase Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Alpha1-Proteinase Inhibitor Sales by Country (2020-2031)
3.4.3 North America Alpha1-Proteinase Inhibitor Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alpha1-Proteinase Inhibitor Market Facts & Figures by Country
3.5.1 Europe Alpha1-Proteinase Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Alpha1-Proteinase Inhibitor Sales by Country (2020-2031)
3.5.3 Europe Alpha1-Proteinase Inhibitor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alpha1-Proteinase Inhibitor Market Facts & Figures by Region
3.6.1 Asia Pacific Alpha1-Proteinase Inhibitor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Alpha1-Proteinase Inhibitor Sales by Region (2020-2031)
3.6.3 Asia Pacific Alpha1-Proteinase Inhibitor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alpha1-Proteinase Inhibitor Market Facts & Figures by Country
3.7.1 Latin America Alpha1-Proteinase Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Alpha1-Proteinase Inhibitor Sales by Country (2020-2031)
3.7.3 Latin America Alpha1-Proteinase Inhibitor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alpha1-Proteinase Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa Alpha1-Proteinase Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Country (2020-2031)
3.8.3 Middle East and Africa Alpha1-Proteinase Inhibitor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alpha1-Proteinase Inhibitor Sales by Type (2020-2031)
4.1.1 Global Alpha1-Proteinase Inhibitor Sales by Type (2020-2025)
4.1.2 Global Alpha1-Proteinase Inhibitor Sales by Type (2026-2031)
4.1.3 Global Alpha1-Proteinase Inhibitor Sales Market Share by Type (2020-2031)
4.2 Global Alpha1-Proteinase Inhibitor Revenue by Type (2020-2031)
4.2.1 Global Alpha1-Proteinase Inhibitor Revenue by Type (2020-2025)
4.2.2 Global Alpha1-Proteinase Inhibitor Revenue by Type (2026-2031)
4.2.3 Global Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2020-2031)
4.3 Global Alpha1-Proteinase Inhibitor Price by Type (2020-2031)
5 Segment by Application
5.1 Global Alpha1-Proteinase Inhibitor Sales by Application (2020-2031)
5.1.1 Global Alpha1-Proteinase Inhibitor Sales by Application (2020-2025)
5.1.2 Global Alpha1-Proteinase Inhibitor Sales by Application (2026-2031)
5.1.3 Global Alpha1-Proteinase Inhibitor Sales Market Share by Application (2020-2031)
5.2 Global Alpha1-Proteinase Inhibitor Revenue by Application (2020-2031)
5.2.1 Global Alpha1-Proteinase Inhibitor Revenue by Application (2020-2025)
5.2.2 Global Alpha1-Proteinase Inhibitor Revenue by Application (2026-2031)
5.2.3 Global Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2020-2031)
5.3 Global Alpha1-Proteinase Inhibitor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Alpha1-Proteinase Inhibitor Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Kamada
6.2.1 Kamada Company Information
6.2.2 Kamada Description and Business Overview
6.2.3 Kamada Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Kamada Alpha1-Proteinase Inhibitor Product Portfolio
6.2.5 Kamada Recent Developments/Updates
6.3 Talecris Biotherapeutics
6.3.1 Talecris Biotherapeutics Company Information
6.3.2 Talecris Biotherapeutics Description and Business Overview
6.3.3 Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Product Portfolio
6.3.5 Talecris Biotherapeutics Recent Developments/Updates
6.4 Aventis
6.4.1 Aventis Company Information
6.4.2 Aventis Description and Business Overview
6.4.3 Aventis Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Aventis Alpha1-Proteinase Inhibitor Product Portfolio
6.4.5 Aventis Recent Developments/Updates
6.5 CSL Behring
6.5.1 CSL Behring Company Information
6.5.2 CSL Behring Description and Business Overview
6.5.3 CSL Behring Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CSL Behring Alpha1-Proteinase Inhibitor Product Portfolio
6.5.5 CSL Behring Recent Developments/Updates
6.6 Grifols
6.6.1 Grifols Company Information
6.6.2 Grifols Description and Business Overview
6.6.3 Grifols Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Grifols Alpha1-Proteinase Inhibitor Product Portfolio
6.6.5 Grifols Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alpha1-Proteinase Inhibitor Industry Chain Analysis
7.2 Alpha1-Proteinase Inhibitor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alpha1-Proteinase Inhibitor Production Mode & Process Analysis
7.4 Alpha1-Proteinase Inhibitor Sales and Marketing
7.4.1 Alpha1-Proteinase Inhibitor Sales Channels
7.4.2 Alpha1-Proteinase Inhibitor Distributors
7.5 Alpha1-Proteinase Inhibitor Customer Analysis
8 Alpha1-Proteinase Inhibitor Market Dynamics
8.1 Alpha1-Proteinase Inhibitor Industry Trends
8.2 Alpha1-Proteinase Inhibitor Market Drivers
8.3 Alpha1-Proteinase Inhibitor Market Challenges
8.4 Alpha1-Proteinase Inhibitor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Kamada
Grifols S A
CSL Behring
Baxter
Talecris Biotherapeutics
Aventis
List of Tables
 Table 1. Global Alpha1-Proteinase Inhibitor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Alpha1-Proteinase Inhibitor Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Alpha1-Proteinase Inhibitor Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Alpha1-Proteinase Inhibitor Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Alpha1-Proteinase Inhibitor Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Alpha1-Proteinase Inhibitor Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Alpha1-Proteinase Inhibitor Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Alpha1-Proteinase Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Alpha1-Proteinase Inhibitor, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Alpha1-Proteinase Inhibitor, Product Type & Application
 Table 12. Global Key Manufacturers of Alpha1-Proteinase Inhibitor, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alpha1-Proteinase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha1-Proteinase Inhibitor as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alpha1-Proteinase Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Alpha1-Proteinase Inhibitor Sales by Region (2020-2025) & (K MT)
 Table 18. Global Alpha1-Proteinase Inhibitor Sales Market Share by Region (2020-2025)
 Table 19. Global Alpha1-Proteinase Inhibitor Sales by Region (2026-2031) & (K MT)
 Table 20. Global Alpha1-Proteinase Inhibitor Sales Market Share by Region (2026-2031)
 Table 21. Global Alpha1-Proteinase Inhibitor Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2020-2025)
 Table 23. Global Alpha1-Proteinase Inhibitor Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2026-2031)
 Table 25. North America Alpha1-Proteinase Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Alpha1-Proteinase Inhibitor Sales by Country (2020-2025) & (K MT)
 Table 27. North America Alpha1-Proteinase Inhibitor Sales by Country (2026-2031) & (K MT)
 Table 28. North America Alpha1-Proteinase Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Alpha1-Proteinase Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Alpha1-Proteinase Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Alpha1-Proteinase Inhibitor Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Alpha1-Proteinase Inhibitor Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Alpha1-Proteinase Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Alpha1-Proteinase Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Alpha1-Proteinase Inhibitor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Alpha1-Proteinase Inhibitor Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Alpha1-Proteinase Inhibitor Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Alpha1-Proteinase Inhibitor Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Alpha1-Proteinase Inhibitor Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Alpha1-Proteinase Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Alpha1-Proteinase Inhibitor Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Alpha1-Proteinase Inhibitor Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Alpha1-Proteinase Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alpha1-Proteinase Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Alpha1-Proteinase Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Alpha1-Proteinase Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Alpha1-Proteinase Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Alpha1-Proteinase Inhibitor Sales (K MT) by Type (2020-2025)
 Table 51. Global Alpha1-Proteinase Inhibitor Sales (K MT) by Type (2026-2031)
 Table 52. Global Alpha1-Proteinase Inhibitor Sales Market Share by Type (2020-2025)
 Table 53. Global Alpha1-Proteinase Inhibitor Sales Market Share by Type (2026-2031)
 Table 54. Global Alpha1-Proteinase Inhibitor Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Alpha1-Proteinase Inhibitor Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2020-2025)
 Table 57. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2026-2031)
 Table 58. Global Alpha1-Proteinase Inhibitor Price (USD/MT) by Type (2020-2025)
 Table 59. Global Alpha1-Proteinase Inhibitor Price (USD/MT) by Type (2026-2031)
 Table 60. Global Alpha1-Proteinase Inhibitor Sales (K MT) by Application (2020-2025)
 Table 61. Global Alpha1-Proteinase Inhibitor Sales (K MT) by Application (2026-2031)
 Table 62. Global Alpha1-Proteinase Inhibitor Sales Market Share by Application (2020-2025)
 Table 63. Global Alpha1-Proteinase Inhibitor Sales Market Share by Application (2026-2031)
 Table 64. Global Alpha1-Proteinase Inhibitor Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Alpha1-Proteinase Inhibitor Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2020-2025)
 Table 67. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2026-2031)
 Table 68. Global Alpha1-Proteinase Inhibitor Price (USD/MT) by Application (2020-2025)
 Table 69. Global Alpha1-Proteinase Inhibitor Price (USD/MT) by Application (2026-2031)
 Table 70. Baxter Company Information
 Table 71. Baxter Description and Business Overview
 Table 72. Baxter Alpha1-Proteinase Inhibitor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Baxter Alpha1-Proteinase Inhibitor Product
 Table 74. Baxter Recent Developments/Updates
 Table 75. Kamada Company Information
 Table 76. Kamada Description and Business Overview
 Table 77. Kamada Alpha1-Proteinase Inhibitor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Kamada Alpha1-Proteinase Inhibitor Product
 Table 79. Kamada Recent Developments/Updates
 Table 80. Talecris Biotherapeutics Company Information
 Table 81. Talecris Biotherapeutics Description and Business Overview
 Table 82. Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Product
 Table 84. Talecris Biotherapeutics Recent Developments/Updates
 Table 85. Aventis Company Information
 Table 86. Aventis Description and Business Overview
 Table 87. Aventis Alpha1-Proteinase Inhibitor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Aventis Alpha1-Proteinase Inhibitor Product
 Table 89. Aventis Recent Developments/Updates
 Table 90. CSL Behring Company Information
 Table 91. CSL Behring Description and Business Overview
 Table 92. CSL Behring Alpha1-Proteinase Inhibitor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. CSL Behring Alpha1-Proteinase Inhibitor Product
 Table 94. CSL Behring Recent Developments/Updates
 Table 95. Grifols Company Information
 Table 96. Grifols Description and Business Overview
 Table 97. Grifols Alpha1-Proteinase Inhibitor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Grifols Alpha1-Proteinase Inhibitor Product
 Table 99. Grifols Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Alpha1-Proteinase Inhibitor Distributors List
 Table 103. Alpha1-Proteinase Inhibitor Customers List
 Table 104. Alpha1-Proteinase Inhibitor Market Trends
 Table 105. Alpha1-Proteinase Inhibitor Market Drivers
 Table 106. Alpha1-Proteinase Inhibitor Market Challenges
 Table 107. Alpha1-Proteinase Inhibitor Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alpha1-Proteinase Inhibitor
 Figure 2. Global Alpha1-Proteinase Inhibitor Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alpha1-Proteinase Inhibitor Market Share by Type: 2024 & 2031
 Figure 4. Powder Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global Alpha1-Proteinase Inhibitor Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Alpha1-Proteinase Inhibitor Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Alpha1-Proteinase Inhibitor Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Alpha1-Proteinase Inhibitor Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Alpha1-Proteinase Inhibitor Sales (2020-2031) & (K MT)
 Figure 13. Global Alpha1-Proteinase Inhibitor Average Price (USD/MT) & (2020-2031)
 Figure 14. Alpha1-Proteinase Inhibitor Report Years Considered
 Figure 15. Alpha1-Proteinase Inhibitor Sales Share by Manufacturers in 2024
 Figure 16. Global Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Alpha1-Proteinase Inhibitor Players: Market Share by Revenue in Alpha1-Proteinase Inhibitor in 2024
 Figure 18. Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Alpha1-Proteinase Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Alpha1-Proteinase Inhibitor Sales Market Share by Country (2020-2031)
 Figure 21. North America Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Alpha1-Proteinase Inhibitor Sales Market Share by Country (2020-2031)
 Figure 25. Europe Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Alpha1-Proteinase Inhibitor Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2020-2031)
 Figure 33. China Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Alpha1-Proteinase Inhibitor Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Alpha1-Proteinase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Alpha1-Proteinase Inhibitor by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Alpha1-Proteinase Inhibitor by Type (2020-2031)
 Figure 55. Global Alpha1-Proteinase Inhibitor Price (USD/MT) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Alpha1-Proteinase Inhibitor by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Alpha1-Proteinase Inhibitor by Application (2020-2031)
 Figure 58. Global Alpha1-Proteinase Inhibitor Price (USD/MT) by Application (2020-2031)
 Figure 59. Alpha1-Proteinase Inhibitor Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Human Alpha1 Proteinase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Trypsin Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Alpha 1 Antitrypsin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alpha Protease Inhibitor Market Research Report 2025
Alpha 1 Lung Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Trypsin Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antipain Dihydrochloride Market Research Report 2024
Global Pepstatin A Market Research Report 2024
Industrial Proteases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Trypsin Liquid Solution Market Insights Forecast to 2030
Global Alpha 2 Antiplasmin Market Research Report 2024
Global Human Trypsin Market Research Report 2024
Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Research Report 2024
Global Recombinant Trypsin Market Insights Forecast to 2030
Global Recombinant Trypsin Solution Market Research Report 2025
Global Human Plasma Protein Products Market Research Report 2024
Animal Free Trypsin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Component free Trypsin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Plasma Proteins Market Insights Forecast to 2030
C1 Esterase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions